FDA Approves Journavx Drug to Treat Pain Without Addiction Risk

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.

Bernie Sanders and R.F.K. Jr. Clash Over Vaccines and Health Care

In a Senate hearing, Senator Bernie Sanders pushed Robert F. Kennedy Jr. again on his past support for unsupported claims that vaccines caused autism.

Pause on U.S. Funding Spreads Fear of H.I.V. Spike Across Africa

Patients and health care advocates said the abrupt decision to halt U.S. funding for a lifesaving H.I.V. program led to widespread confusion. The backtracking didn’t help.

New CVS App Lets Customers Unlock Cabinets to Pick Up Products

The company said the unlocking function, part of a pilot program in New York City, will be expanded this year.

F.D.A. Approves Ozempic to Treat Kidney Disease

The decision will further broaden the use of the blockbuster drug.

Trump Administration Halts H.I.V. Drug Distribution in Poor Countries

PEPFAR’s computer systems also are being taken offline, a sign that the program may not return, as Republican critics had hoped.

Would You Get Sick in the Name of Science?

Since the pandemic, drug trials that purposely make people vomit, shiver and ache have become a research area of growing interest. All that’s needed: brave volunteers.

In China, Government Data on Drugs Blocked From Public After Backlash

Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the quality of medicine.

Gazans Trek Home, and Trump’s Tariff Spat With Colombia

Plus, a Super Bowl three-peat?

In China, Rare Dissent Over a Program to Save on Drug Costs

Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.